METHOD FOR SELECTING A TREATMENT FOR NON-SMALL CELL LUNG CANCER USING GENE EXPRESSION PROFILES
Patent №
US 8,722,331
Granted
2014-05-13
Filed 2004
Owner
MEDICAL COLLEGE OF OHIO
+1 more
Lab
—
AI components
1
vision
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
10508932
The present invention identifies and quantifies changes in gene expression associated with non-small cell lung cancer NSCLC by examining gene expression in tissue from normal lung and diseased lung. The present invention also identifies and quantifies expression profiles which serve as useful diagnostic markers as well as markers that are useful to monitor disease states, disease progression, drug toxicity, drug efficacy and drug metabolism.
AI classification
Ownership
MEDICAL COLLEGE OF OHIO
assignment · 164130791
MEDICAL UNIVERSITY OF OHIO
namechg · 255850593
Assignors
WILLEY, JAMES C., DEMUTH, JEFFREY P., CRAWFORD, ERIN L., WEAVER, DAVID A., WARNER, KRISTY A., GRAVES, TIMOTHY G.
On an employer assignment, the assignors are typically the inventors.